CIK 0001770121 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831381173
- Phone
- (206) 701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Bilenker Joshua H. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | Mulligan Richard Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | Wilderotter Mary Agnes Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | Seitz Michelle Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | REICIN ALISE Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | Cole Douglas G. Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | Bishop Hans Edgar Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | Bilenker Joshua H. Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-06-06 | Yang Patrick Y Director | Grant or award · Stock Option (Right to Buy) | +54,278 | 54,278 | ||
| 2024-04-05 | Bishop Hans Edgar Director | Grant or award | +2,774 | 5,779,640 | ||
| 2024-03-08 | Yang Patrick Y Director | Sale | −25,000 | $9.45 | $236K | 149,250 |
| 2024-03-07 | WILLIAMS DOUGLAS E EVP & President, R&D | Grant or award · Restricted Stock Units | +67,083 | 67,083 | ||
| 2024-03-07 | WILLIAMS DOUGLAS E EVP & President, R&D | Grant or award · Stock Option (Right to Buy) | +301,875 | 301,875 | ||
| 2024-03-07 | Harr Steve President & CEO | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2024-03-07 | Harr Steve President & CEO | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2024-03-07 | Hordo Christian EVP, Chief Business Officer | Grant or award · Restricted Stock Units | +37,500 | 37,500 | ||
| 2024-03-07 | Hordo Christian EVP, Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | ||
| 2024-03-07 | Hardy Nathan EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +67,083 | 67,083 | ||
| 2024-03-07 | Hardy Nathan EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +301,875 | 301,875 |
Page 6 of 9 · 172 trades